The oral antimalarial artesunate/amodiaquine [Arsucan; Sanofi-Synthélabo] has been launched in Kenya

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1436, 2004-01, pp. : 18-18

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sanofi Pasteur MSD's recombinant quadrivalent human papillomavirus (HPV) vaccine [Gardasil] has been launched in 15 EU countries

Inpharma, Vol. 1, Iss. 1575, 2007-01 ,pp. : 23-23

Adis International

Access to resources Recommend Favorite

The antimalarial combination of artemisinin plus naphthoquine [Arco] has been launched in Nigeria

Inpharma, Vol. 1, Iss. 1548, 2006-01 ,pp. : 22-22

Adis International

Access to resources Recommend Favorite

Artesunate–amodiaquine for the treatment of uncomplicated malaria

By Sirima Sodiomon Bienvenu Gansané Adama

Expert Opinion on Investigational Drugs, Vol. 16, Iss. 7, 2007-06 ,pp. : 1079-1085

Informa Healthcare

Access to resources Recommend Favorite

A massive 1-week measles vaccination campaign totalling $US15 million has been launched in Kenya, Africa

Inpharma, Vol. 1, Iss. 1344, 2002-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Rectal artesunate has rapid antimalarial efficacy

Inpharma, Vol. 1, Iss. 1438, 2004-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite